What is VoluMetrix?
VoluMetrix is a Nashville-based innovator dedicated to advancing vital monitoring solutions to enhance well-being. The company is pioneering non-invasive venous waveform technology, working collaboratively with patients and healthcare practitioners to optimize the implementation and utilization of its groundbreaking systems, spanning from hospital settings to home care. VoluMetrix's NIVA technology is currently investigational and not yet available for sale in the United States. Its research and development efforts have been supported by grants from the National Heart, Lung and Blood Institute of the National Institutes of Health.
How much funding has VoluMetrix raised?
VoluMetrix has raised a total of $308K across 2 funding rounds:
Debt
$150K
Debt
$158K
Debt (2020): $150K with participation from PPP
Debt (2021): $158K led by PPP
Key Investors in VoluMetrix
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for VoluMetrix?
With substantial late-stage funding, VoluMetrix is poised to accelerate the development and potential commercialization of its investigational NIVA technology. The company's strategic partnerships with institutions like Vanderbilt University Medical Center and the Mayo Clinic Innovation Exchange suggest a clear pathway towards clinical validation and broader adoption. Future efforts will likely focus on navigating regulatory pathways and scaling production to meet the anticipated demand for advanced vital monitoring solutions, aiming to establish a new standard in patient care from acute settings to remote monitoring.
See full VoluMetrix company page
